CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner2 Banner4 Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
New fund eases expenses for organ donors
01-29-2015
Quest in broad deal with CDC for hepatitis analysis
01-27-2015
PBM EnvisionRx chooses Gilead hepatitis C drugs for its formulary
01-26-2015
FDA approves iron replacement drug
01-26-2015
View Complete News Library
 
 
February 3-6
LIVER WEEK 2015
STOCKHOLM
February 27- March 2
CDDW: Canadian Digestive Diseases Week and Annual Canadian Association for the Study of the Liver (CASL) 2015 Meeting
Banff, Alberta
March 12-15
25th ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF LIVER (APASL)
Brisbane
April 22-26
The International Liver Congress 2015, 50th annual meeting of the European Association for the Study of the Liver (EASL)
Vienna, Austria
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Resolute efforts to cure hepatitis C: Understanding patients' reasons for completing antiviral treatment
 
Outcomes in Liver Transplantation: Does Sex Matter?
 
Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study
 
An Interferon-free Antiviral Regimen for HCV after Liver Transplantation
 
A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing
 
Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C?
 
 
Recent FDA warnings on hepatitis B reactivation with immune-suppressing and anti-cancer drugs: Just the tip of the iceberg?
 
Incidence of Hepatocellular Carcinoma after HBsAg Seroclearance in Chronic Hepatitis B Patients: a Need for Surveillance
 
Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
 
Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach
 
Is There a Role for Probiotics in Liver Disease?
 
Covert hepatic encephalopathy: Agreement and predictive validity of different indices
 
 
Rifaximin: a review of its use in reducing recurrence of overt hepatic encephalopathy episodes
 
Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
 
Development of risk scoring system for stratifying population for hepatocellular-carcinoma screening
 
Hepatitis C Virus-Associated Cancer
 
Treatment of hepatocellular carcinoma with child-pugh C cirrhosis
 
Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.